Back to Search
NICHOLAS MICHAUD, PHARMD
PHARMD
Pharmacist
NPI: 1386097533Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PI145416(ME)
Research & Publications (20)
The regulated in development and DNA damage response 2 (REDD2) gene mediates human monocyte cell death through a reduction in thioredoxin-1 expression.
PMID 19268525·Free Radic Biol Med·2009
8-other
Overexpression of rhodopsin alters the structure and photoresponse of rod photoreceptors.
PMID 19186132·Biophys J·2009
7-preclinical
HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice.
PMID 18497877·J Clin Invest·2008
7-preclinical
Transducin gamma-subunit sets expression levels of alpha- and beta-subunits and is crucial for rod viability.
PMID 18367617·J Neurosci·2008
7-preclinical
Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.
PMID 18296663·Invest Ophthalmol Vis Sci·2008
7-preclinical
Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PET.
PMID 18077531·J Nucl Med·2008
7-preclinical
Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.
PMID 17924347·Am J Hum Genet·2007
7-preclinical
Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
PMID 17460290·Invest Ophthalmol Vis Sci·2007
7-preclinical
The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion.
PMID 17360635·Proc Natl Acad Sci U S A·2007
4-observational
Mpp4 is required for proper localization of plasma membrane calcium ATPases and maintenance of calcium homeostasis at the rod photoreceptor synaptic terminals.
PMID 17341488·Hum Mol Genet·2007
7-preclinical
Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma.
PMID 17151265·J Neurosci·2006
4-observational
Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
PMID 16723479·Invest Ophthalmol Vis Sci·2006
7-preclinical
Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
PMID 16723462·Invest Ophthalmol Vis Sci·2006
7-preclinical
Effects of low AIPL1 expression on phototransduction in rods.
PMID 16639031·Invest Ophthalmol Vis Sci·2006
7-preclinical
Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.
PMID 16384985·Invest Ophthalmol Vis Sci·2006
7-preclinical
Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
PMID 15824225·Arch Ophthalmol·2005
7-preclinical
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
PMID 15249365·Arch Ophthalmol·2004
7-preclinical
Comparison of two beta-glucosidases for the enzymatic synthesis of beta-(1-6)-beta-(1-3)-gluco-oligosaccharides.
PMID 15200180·Biotechnol Lett·2004
4-observational
Phosducin facilitates light-driven transducin translocation in rod photoreceptors. Evidence from the phosducin knockout mouse.
PMID 14973130·J Biol Chem·2004
7-preclinical
Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
PMID 14698677·Neuropeptides·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 PEACHTREE ST NE
ATLANTA, GA 30308 - Phone
- (404) 686-3813
Quick Facts
- NPI
- 1386097533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile